Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Protein Biochemistry
Chemicals and Reagents
Atuveciclib
Atuveciclib from MedChemExpress
Be the first to write a review!
Citations:
(2)
Supplier Page
Supplier Page from
MedChemExpress for
Atuveciclib
Get Pricing
Description
Atuveciclib (BAY-1143572) is a potent and highly selective, oral
PTEFb
/
CDK9
inhibitor. Atuveciclib (BAY-1143572) inhibits
CDK9
/
CycT1
with an
IC
50
of 13 nM
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Atuveciclib
Company
MedChemExpress
Price
$308.00
Supplier Page
View Company Product Page
Catalog Number
HY-12871B
Quantity
10 mM * 1 mL
Applications
Bioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity
99.75%
Type
Chemical
Molecular Weight
387.43
Formula
C₁₈H₁₈FN₅O₂S
Research Area
Cancer
Add to Compare List
MedChemExpress
1 Deer Park Drive, Suite F
MONMOUTH JUNCTION
,
NJ
08852
United States
Phone
: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910
Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com
Company Profile
Website:
medchemexpress.com
Citations (2)
(1)
Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors
Breast Cancer Research
May 5, 2023
Vera E. van der Noord, Wanda van der Stel, Gijs Louwerens, Danielle Verhoeven, Hendrik J. Kuiken, Cor Lieftink, Melanie Grandits, Gerhard F. Ecker, Roderick L. Beijersbergen, Peter Bouwman,
et al.
Selleckchem
. CDKI-73 was provided by Prof. S. Wang (University of South-Australia) [22]. BAY-143572 (
HY-12871B
),
THZ1
(
HY-80013A
),
THZ531
(
HY-103618
), SR4835 (
HY-130250
), nilotinib (
HY-10159
), rabusertib (LY2603618,
(2)
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer
ChemMedChem
November 8, 2017
Lücking U, Scholz A, Lienau P, Siemeister G, Kosemund D, Bohlmann R, Briem H, Terebesi I, Meyer K, Prelle K,
et al
.
<<
<
>
>>
Reviews
Be the First to Write a Review!
Atuveciclib from MedChemExpress
Supplier Page
View Company Product Page
$308.00
Product Specs
Company Info
Citations
Reviews
Back To Top